BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7886112)

  • 1. Increased alcohol intake in low alcohol drinking rats after chronic infusion of the beta-carboline harman into the hippocampus.
    Adell A; Myers RD
    Pharmacol Biochem Behav; 1994 Dec; 49(4):949-53. PubMed ID: 7886112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-HT, dopamine, norepinephrine, and related metabolites in brain of low alcohol drinking (LAD) rats shift after chronic intra-hippocampal infusion of harman.
    Adell A; Myers RD
    Neurochem Res; 1995 Feb; 20(2):209-15. PubMed ID: 7540261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Harman induces preference for ethanol in rats: is the effect specific for ethanol?
    Rommelspacher H; Büchau C; Weiss J
    Pharmacol Biochem Behav; 1987 Apr; 26(4):749-55. PubMed ID: 2885856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Action of harman (1-methyl-beta-carboline) on the brain: body temperature and in vivo efflux of 5-HT from hippocampus of the rat.
    Adell A; Biggs TA; Myers RD
    Neuropharmacology; 1996; 35(8):1101-7. PubMed ID: 9121613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-HT2 receptor blockade by amperozide suppresses ethanol drinking in genetically preferring rats.
    Myers RD; Lankford MF; Björk A
    Pharmacol Biochem Behav; 1993 Jul; 45(3):741-7. PubMed ID: 8332634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Harman in rat brain, lung and human CSF: effect of alcohol consumption.
    Bosin TR; Borg S; Faull KF
    Alcohol; 1988; 5(6):505-11. PubMed ID: 3245894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of alcohol preference in high alcohol drinking rats: efficacy of amperozide versus naltrexone.
    Myers RD; Lankford MF
    Neuropsychopharmacology; 1996 Feb; 14(2):139-49. PubMed ID: 8822536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anatomical localization in hippocampus of tetrahydro-beta-carboline-induced alcohol drinking in the rat.
    Huttunen P; Myers RD
    Alcohol; 1987; 4(3):181-7. PubMed ID: 3036178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Voluntary ethanol drinking during the first three postnatal weeks in lines of rats selectively bred for divergent ethanol preference.
    McKinzie DL; Cox R; Murphy JM; Li TK; Lumeng L; McBride WJ
    Alcohol Clin Exp Res; 1999 Dec; 23(12):1892-7. PubMed ID: 10630607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alcohol intake in high alcohol drinking (HAD) rats is suppressed by FG5865, a novel 5-HT1A agonist/5-HT2 antagonist.
    Long TA; Kalmus GW; Björk A; Myers RD
    Pharmacol Biochem Behav; 1996 Jan; 53(1):33-40. PubMed ID: 8848457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mixed 5-HT 1A/2A receptor drug FG5938 suppresses alcohol drinking while enhancing feeding in P rats.
    Piercy KT; Björk AK; Myers RD
    Alcohol; 1996; 13(5):521-7. PubMed ID: 8888950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Harman-induced changes of extracellular concentrations of neurotransmitters in the nucleus accumbens of rats.
    Baum SS; Hill R; Rommelspacher H
    Eur J Pharmacol; 1996 Oct; 314(1-2):75-82. PubMed ID: 8957221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central action of an inhibitor of brain dopa-decarboxylase, NSD-1015, on cyanamide-induced alcohol drinking in rats.
    Miñano FJ; McMillen BA; Myers RD
    Pharmacol Biochem Behav; 1990 Feb; 35(2):465-8. PubMed ID: 2320657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of brain dopa-decarboxylase by RO 4-4602 infused ICV blocks alcohol drinking induced in rats by cyanamide.
    Miñano FJ; Myers RD
    Psychopharmacology (Berl); 1989; 98(2):176-82. PubMed ID: 2502790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective reduction by the 5-HT antagonist amperozide of alcohol preference induced in rats by systemic cyanamide.
    Myers RD; Lankford M; Björk A
    Pharmacol Biochem Behav; 1992 Nov; 43(3):661-7. PubMed ID: 1448464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of neuropeptide Y on sucrose and ethanol intake and on anxiety-like behavior in high alcohol drinking (HAD) and low alcohol drinking (LAD) rats.
    Badia-Elder NE; Stewart RB; Powrozek TA; Murphy JM; Li TK
    Alcohol Clin Exp Res; 2003 Jun; 27(6):894-9. PubMed ID: 12824809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of harman and harmine on naloxone-precipitated withdrawal syndrome in morphine-dependent rats.
    Aricioglu-Kartal F; Kayir H; Tayfun Uzbay I
    Life Sci; 2003 Sep; 73(18):2363-71. PubMed ID: 12941438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic intracerebroventricular administration of recombinant CART(42-89) peptide inhibits and causes weight loss in lean and obese Zucker (fa/fa) rats.
    Larsen PJ; Vrang N; Petersen PC; Kristensen P
    Obes Res; 2000 Nov; 8(8):590-6. PubMed ID: 11156435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benzodiazepine receptor ligands modulate ethanol drinking in alcohol-preferring rats.
    Wegelius K; Honkanen A; Korpi ER
    Eur J Pharmacol; 1994 Sep; 263(1-2):141-7. PubMed ID: 7821345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycyl-L-glutamine injected centrally suppresses alcohol drinking in P rats.
    Simpson CW; Resch GE; Millington WR; Myers RD
    Alcohol; 1998 Aug; 16(2):101-7. PubMed ID: 9665311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.